Phoenix Rising tells QMUL: release the PACE trial data
Mark Berry, Acting CEO of Phoenix Rising, presents the Board of Directors’ open letter to Queen Mary University of London (QMUL) urging them to release the PACE trial data, and hopes that other non-UK organisations will join British charities in the same request...
Discuss the article on the Forums.

Long term safety study of Rituximab for treating RA

Discussion in 'Other Health News and Research' started by user9876, Jan 9, 2013.

  1. user9876

    user9876 Senior Member

    Messages:
    1,769
    Likes:
    10,522
    Reasuring results I think. Infection rates didn't seem to go up compared to control group.

    http://www.ncbi.nlm.nih.gov/pubmed/23136242
     
    Shell, heapsreal, alex3619 and 4 others like this.

See more popular forum discussions.

Share This Page